Global digital health brand ResMed has pledged to invest €30 million in research and development (R&D) in Ireland, opening a new facility in Sandyford, Dublin on Tuesday.
The San Diego-based company also announced plans to double its Ireland-based software and technology team over the next four years, introducing 70 jobs to support innovation, technology and product development. increase.
According to ResMed, roles include “highly skilled and highly paid roles” such as mobile, AWS and full-stack software developers and algorithm/machine learning engineers.
The company is a leading provider of connected devices, masks and accessories for treating sleep apnea.
The opening of the new Sandyford facility was attended by Tánaiste Leo Varadkar, who welcomed ResMed’s investment.
“Ireland has become globally recognized for its workforce talent, particularly in the areas of healthcare technology and medical devices,” said Varadkar.
“ResMed’s products are making a real difference to so many people’s lives and it’s great that Ireland is playing a key role in that effort.”
“This investment by ResMed has been very well received and demonstrates the company’s commitment to Ireland,” added Mary Buckley, Executive Director of IDA Ireland.
It is also the endorsement of a talented team in Dublin who have won this R&D assignment due to their track record of delivering innovative solutions. ”
